SCHEMBL16731600

SCHEMBL16731600

CC(=O)c1ccc2c(c1)C(=O)c1cc(C(=O)OC(=O)c3ccccc3)ccc1-2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S100A4 P26447 1/20 0.59
▸ TTR P02766 2/20 0.50
▸ MAPT P10636 5/20 0.49
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ LMNA P02545 2/20 0.49
▸ PTPRC P08575 3/20 0.49
▸ ACE2 Q9BYF1 1/20 0.43
▸ HTR7 P34969 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CTSL P07711 1/20 0.40
▸ PTPN13 Q12923 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16731946 0.92 TTR (0.58) S100A4TTRMAPTNPC1RAB9A
SCHEMBL6934221 0.84 TTR (0.65) S100A4TTRMAPTNPC1RAB9A
SCHEMBL31268599 0.82 S100A4 (0.86) S100A4TTRMAPTNPC1RAB9A
SCHEMBL27624591 0.82 KMT2A (0.51) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6933741 0.82 TTR (0.67) S100A4TTRMAPTNPC1RAB9A
SCHEMBL8014885 0.82 S100A4 (0.86) S100A4TTRMAPTNPC1RAB9A
SCHEMBL10947293 0.82 S100A4 (0.71) S100A4TTRMAPTNPC1RAB9A
SCHEMBL13172184 0.81 RAB9A (0.68) S100A4MAPTNPC1RAB9AALDH1A1
SCHEMBL10881228 0.80 S100A4 (0.82) S100A4TTRMAPTNPC1RAB9A
SCHEMBL775792 0.80 SMN1; SMN2 (0.59) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141665-A1 METHODS FOR PREPARING POLYMERIC REAGENTS NEKTAR THERAPEUTICS (US) 2015-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141665-A1 METHODS FOR PREPARING POLYMERIC REAGENTS PAM, ALKBH3, DNPEP S100A4 1072/4885TTR 1127/4885MAPT 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback